IMITREX

This brand name is authorized in Canada, Israel, United States

Active ingredients

The drug IMITREX contains one active pharmaceutical ingredient (API):

1 Sumatriptan UNII J8BDZ68989 - SUMATRIPTAN SUCCINATE

Sumatriptan has been demonstrated to be a specific and selective 5-Hydroxytryptamine1 (5HT1D) receptor agonist with no effect on other 5HT receptor (5-HT2 - 5-HT7) subtypes. The vascular 5-HT1D receptor is found predominantly in cranial blood vessels and mediates vasoconstriction. Read about Sumatriptan

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
IMITREX Film-coated tablet	FDA, National Drug Code (US)	MPI, US: SPL/PLR
IMITREX Nasal spray	FDA, National Drug Code (US)	MPI, US: SPL/PLR
IMITREX Solution for injection	FDA, National Drug Code (US)	MPI, US: SPL/PLR

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
N02CC01	Sumatriptan	N Nervous system → N02 Analgesics → N02C Antimigraine preparations → N02CC Selective serotonin (5HT1) agonists
Discover more medicines within N02CC01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: CA	Health Products and Food Branch	Identifier(s): 02212153, 02212161, 02212188, 02230418, 02230420
Country: IL	מִשְׂרַד הַבְּרִיאוּת	Identifier(s): 268, 270, 3408, 4088
Country: US	FDA, National Drug Code	Identifier(s): 0173-0449, 0173-0478, 0173-0479, 0173-0523, 0173-0524, 0173-0735, 0173-0736, 0173-0737, 0173-0739